Literature DB >> 6409475

Rabbit autoantibodies to actin induced by immunization with heterologous actins; a possible mechanism of smooth muscle antibody production.

M Nishioka, S Watanabe, K Kobayashi, T Nakamura.   

Abstract

Antisera against actins from chicken gizzard smooth muscle and ascaris body wall were prepared in rabbits. Immunological cross-reactivity of the antisera with actins of several different species was demonstrated by precipitation reactions in agarose gels and by immunofluorescence studies. The antisera were also reactive with actin of rabbits, the homologous animal used for immunization. The latter finding indicated termination of natural tolerance to actin by immunization of cross-reactive actins. A possible mechanism operating in the induction of smooth muscle antibodies, autoantibodies which have a similar nature to the anti-actin antibody is discussed in relation to the termination of natural tolerance to actin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409475      PMCID: PMC1535545     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Indirect immunofluorescence studies of smooth muscle antibodies.

Authors:  P Andersen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

2.  Biochemical and structural studies of actomyosin-like proteins from non-muscle cells. II. Purification, properties, and membrane association of actin from amoebae of Dictyostelium discoideum.

Authors:  J A Spudich
Journal:  J Biol Chem       Date:  1974-09-25       Impact factor: 5.157

3.  The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin.

Authors:  J A Spudich; S Watt
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

4.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

5.  Production of antibody to homologous -fetoprotein in rabbits, rats and horses by immunization with human -fetoprotein.

Authors:  S Nishi; H Watabe; H Hirai
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

6.  Smooth muscle antibody in malignant disease.

Authors:  J M Whitehouse; E J Holborow
Journal:  Br Med J       Date:  1971-11-27

7.  Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells.

Authors:  G Gabbiani; G B Ryan; J P Lamelin; P Vassalli; G Majno; C A Bouvier; A Cruchaud; E F Lüscher
Journal:  Am J Pathol       Date:  1973-09       Impact factor: 4.307

8.  Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis.

Authors:  L J Farrow; E J Holborow; G D Johnson; S G Lamb; J S Stewart; P E Taylor; A J Zuckerman
Journal:  Br Med J       Date:  1970-06-20

9.  Actin antibody: the specific visualization of actin filaments in non-muscle cells.

Authors:  E Lazarides; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

10.  The termination of immunological unresponsiveness to bovine serum albumin in rabbits. I. Quantitative and qualitative response to cross-reacting albumins.

Authors:  D C Benjamin; W O Weigle
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

View more
  3 in total

1.  Detection and localization of actin in Toxoplasma gondii.

Authors:  T Endo; K Yagita; T Yasuda; T Nakamura
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

2.  Immunocytochemical localization of actin in Toxoplasma gondii.

Authors:  T Yasuda; K Yagita; T Nakamura; T Endo
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

Review 3.  Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.

Authors:  Takashi Himoto; Mikio Nishioka
Journal:  Auto Immun Highlights       Date:  2013-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.